PMID: 3756765Nov 15, 1986Paper

125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree

Cancer
R R DobelbowerR T Skeel

Abstract

Twelve patients with adenocarcinoma of the pancreas and two patients with carcinoma of the extrahepatic biliary tree received combined therapy with 125I implant, precision high-dose (PHD) photon external beam therapy, and systemic 5-fluorouracil (5-FU). The 125I implant delivered 120 to 210 Gy (median 140 Gy). PHD external beam therapy was given with high-energy photons (10, 15 or 45 meVp) and was initiated 4 to 6 weeks postimplant. A dose of 48.6 to 63 Gy was delivered over 5.5 to 7 weeks in 1.8 Gy increments. Six patients received 5-FU, 500 mg/m2 via weekly intravenous bolus injection. No patient was lost to follow-up (range, 3.5-57 months). Acute postoperative morbidity included pancreatic fistula in two patients and gastrointestinal tract bleeding, pulmonary embolism, and cholangitis in one patient each. No patient died of radiation complications. Median survival of the patients with pancrease cancer was 15 months. One patient is alive at 41 months with hepatic metastasis. Satisfactory palliation was observed in patients with pancreas cancer treated with 125I interstitial implant followed by PHD external beam photon therapy and 5-FU. Patient survival did not seem superior to that of patients treated with PHD external beam t...Continue Reading

References

Oct 1, 1975·International Journal of Radiation Oncology, Biology, Physics·R R DobelbowerN Suntharalingam
Jan 1, 1978·American Journal of Surgery·B B BorgeltK A Strubler
Mar 1, 1978·Cancer·R R DobelbowerK A Strubler
Jan 1, 1975·American Journal of Ophthalmology·W M Grant
Dec 1, 1981·International Journal of Radiation Oncology, Biology, Physics·R WhittingtonS M Weiss
Dec 1, 1984·World Journal of Surgery·E C EllisonL C Carey
Sep 1, 1980·International Journal of Radiation Oncology, Biology, Physics·R R DobelbowerN Suntharalingam
Feb 1, 1981·International Journal of Radiation Oncology, Biology, Physics·A S Al-AbdullaA E Wright

❮ Previous
Next ❯

Citations

Jan 1, 1995·Lasers in Surgery and Medicine·K T MoestaT S Mang
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·P MontemaggiP Marano
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A RabenL B Harrison
Dec 1, 1990·Baillière's Clinical Gastroenterology·R R Dobelbower, D G Bronn
Jul 19, 2001·The Surgical Clinics of North America·R Wagman, A Grann
May 15, 2002·International Journal of Radiation Oncology, Biology, Physics·Hiroyuki ShinchiTakashi Aikou
Nov 3, 1998·Alimentary Pharmacology & Therapeutics·A HaycoxT Walley
Dec 15, 2000·Gastrointestinal Endoscopy·M B Wallace, R H Hawes
Apr 25, 2000·Journal of Clinical Gastroenterology·W R BodnerD A Mastoras
Jan 11, 1991·International Journal of Radiation Oncology, Biology, Physics·R R DobelbowerC Kamen
Jul 1, 1991·International Journal of Radiation Oncology, Biology, Physics·P MontemaggiN Cellini
Jan 1, 1989·International Journal of Radiation Oncology, Biology, Physics·F R BagneD G Bronn
Oct 1, 1990·International Journal of Radiation Oncology, Biology, Physics·F JoyceI Strøyer
Jan 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R R DobelbowerH W Merrick
Nov 1, 1989·International Journal of Radiation Oncology, Biology, Physics·T PeretzM F Brennan
Aug 7, 2007·Seminars in Oncology·Suzanne RussoA William Blackstock
May 30, 2006·Hematology/oncology Clinics of North America·Arthur Y HungLisa A Kachnic
Nov 1, 1988·Seminars in Oncology Nursing·J A SprossM Thorpe
Apr 26, 2012·Journal of Surgical Oncology·Karyn A Goodman, Carla Hajj
Jan 1, 1988·Journal of Pain and Symptom Management·B D MinskyZ Fuks
Jan 1, 1990·Clinical Oncology : a Journal of the Royal College of Radiologists·S R GoertzG A Parker
Jan 19, 2000·The American Journal of Gastroenterology·R H HawesJ L Abbruzzese
Apr 3, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·L PfreundnerK H Fuchs
Feb 25, 1999·Annals of Surgical Oncology·J C PoenJ E Niederhuber
Feb 1, 1989·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·R R DobelbowerD G Bronn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.